Reduced levels of ATP result in decreased inflammation among APS monocytes by blocking unidentified signals stimulated by LPS and inhibiting ATP-mediated production of IL-1 through the inflammasome and IL-10 (194, 195). This evidence concerns the gene IL1B and autoimmune polyendocrinopathy.